Abstract Details

Title Bevacizumab: is the lower the better for glioblastoma patients in progression?

Topic Neuro-oncology

Presentation(s) P5 - (-)

Poster/Presentation
Number 167

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Veronique Bourg (Hopital Pasteur)	No disclosure on file
Lydiane Mondot	Lydiane Mondot has nothing to disclose.
Denys Fontaine, MD, PhD	No disclosure on file
	No disclosure on file
Christine Lebrun Frenay, MD, FAAN (CRCSEP Neurologie)	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique.